Literature DB >> 30543803

Efficacy of Participation-Focused Therapy on Performance of Physical Activity Participation Goals and Habitual Physical Activity in Children With Cerebral Palsy: A Randomized Controlled Trial.

Sarah E Reedman1, Roslyn N Boyd2, Stewart G Trost3, Catherine Elliott4, Leanne Sakzewski2.   

Abstract

OBJECTIVE: To determine the efficacy of a participation-focused therapy (ParticiPAte CP) on leisure-time physical activity goal performance and satisfaction and habitual physical activity (HPA) in children with CP.
DESIGN: Randomized waitlist-controlled trial.
SETTING: Home and community. PARTICIPANTS: Children classified at Gross Motor Function Classification System (GMFCS) levels I-III were recruited (n=37; 18 males; mean age ± SD, 10.0±1.4y) from a population-based register.
INTERVENTIONS: Participants were randomized to ParticiPAte CP (an 8-wk goal-directed, individualized, participation-focused therapy delivered by a physical therapist) or waitlist usual care. MAIN OUTCOME MEASURES: The primary outcome was Canadian Occupational Performance Measure. Accelerometers were worn for objective measurement of HPA (min/d moderate-to-vigorous physical activity [MVPA], sedentary time). Barriers to participation, community participation, and quality-of-life outcomes were also collected. Data were analyzed by intention-to-treat using generalized estimating equations.
RESULTS: ParticiPAte CP led to significant improvements in goal performance (mean difference [MD]=3.58; 95% confidence interval [95% CI], 2.19-4.97; P<.001), satisfaction (MD=1.87; 95% CI, 0.37-3.36, P=.014), and barriers to participation (MD=26.39; 95% CI, 6.13-46.67; P=.011) compared with usual care at 8 weeks. There were no between-group differences on minutes per day of MVPA at 8 weeks (MD=1.17; 95% CI, -13.27 to 15.61; P=.874). There was a significant difference in response to intervention between participants who were versus were not meeting HPA guidelines at baseline (MD=15.85; 95% CI, 3.80-27.89; P<.0061). After ParticiPAte CP, low active participants had increased average MVPA by 5.98±12.16 minutes per day.
CONCLUSION: ParticiPAte CP was effective at increasing perceived performance of leisure-time physical activity goals in children with CP GMFCS I-III by reducing modifiable barriers to participation. This did not translate into change in HPA on average; however, low active children may have a clinically meaningful response.
Copyright © 2018 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cerebral palsy; Leisure; Physical activity; Randomized controlled trial; Rehabilitation

Mesh:

Year:  2018        PMID: 30543803     DOI: 10.1016/j.apmr.2018.11.012

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  4 in total

1.  Machine Learning to Quantify Physical Activity in Children with Cerebral Palsy: Comparison of Group, Group-Personalized, and Fully-Personalized Activity Classification Models.

Authors:  Matthew N Ahmadi; Margaret E O'Neil; Emmah Baque; Roslyn N Boyd; Stewart G Trost
Journal:  Sensors (Basel)       Date:  2020-07-17       Impact factor: 3.576

2.  Athlete-Perceived Impact of Frame Running on Physical Fitness, Functional Mobility and Psychosocial Outcomes.

Authors:  Marietta L Van der Linden; Petra E M Van Schie; Emma Hjalmarsson; Georgia Andreopoulou; Martine H G Verheul; Ferdinand Von Walden
Journal:  J Rehabil Med       Date:  2022-03-01       Impact factor: 2.912

3.  Using a Co-design Approach to Create Tools to Facilitate Physical Activity in Children With Physical Disabilities.

Authors:  Eline A M Bolster; Christa van Gessel; Maxime Welten; Sander Hermsen; Remko van der Lugt; Elles Kotte; Anita van Essen; Manon A T Bloemen
Journal:  Front Rehabil Sci       Date:  2021-11-15

4.  The Impact of Gross Motor Function on the Oral Health-Related Quality of Life in Young Adults with Cerebral Palsy in Saudi Arabia.

Authors:  Sharat Chandra Pani; Saja Fahad AlEidan; Rawan Nasser AlMutairi; AlJawharah Ali AlAbsi; Dalal Nasser AlMuhaidib; Hessa Faisal AlSulaiman; Najd Waleed AlFraih
Journal:  Int J Dent       Date:  2020-02-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.